Close mobile menu×
Close mobile menu

Julie Khlevner, MD

Board Certifications: 
Pediatrics, Pediatric Gastroenterology
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Book Online

Participating DocASAP doctors have online booking available without the need for a myColumbiaDoctors account.

Phone Appointments

New and Existing Patients: 
(212) 305-5903

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Pediatrics
  • Pediatric Gastroenterology

Clinical Expertise

  • Gastroesophageal Reflux Disease
  • Gastrointestinal Disorders
  • Motility disorders of the bowel
  • Esophageal Atresia
  • Bowel Problems
  • Abdominal Pain
  • Motility Disorder, Esophageal
  • Irritable Bowel Syndrome (IBS)
  • Pediatric Gastroenterology
  • Encopresis
  • Constipation
  • Pediatric Gastrointestinal (GI) Endoscopy

Education & Training

  • New York Medical College
  • Internship: Jacobi Hospital - Albert Einstein College of Medicine
  • Residency: Jacobi Hospital - Albert Einstein College of Medicine
  • Fellowship: Stony Brook University Medical Center

About Julie Khlevner

Julie Khlevner, MD, is Director of the Pediatric Gastrointestinal Motility Center and Assistant Professor of Pediatrics at Columbia University Medical Center.

Her unique and rare expertise allows her to evaluate and treat children with functional and gastrointestinal motility disorders using advanced, state-of-the-art diagnostic techniques. Some of the conditions treated by Dr. Khlevner are achalasia, gastroparesis, gastroesophageal reflux disease, chronic abdominal pain, severe constipation, fecal incontinence, and anorectal disorders.

Dr. Khlevner co-directs many multidisciplinary clinics, including Esophageal Atresia Clinic, Aerodigestive Clinic, and Congenital Diaphragmatic Hernia Clinic. She works closely with pediatric surgeons, pulmonologist, cardiologist, ear nose throat (ENT) specialists, and language pathologist to provide the most evidence-based and comprehensive care to children with complex medical problems.

Dr. Khlevner is dedicated to the mission of improving children’s health and is committed to advancing the science of gastrointestinal motility and functional gastrointestinal diseases, with a passion for giving children a better chance at a healthy childhood and a fulfilling life.

Academic Titles

  • Assistant Professor of Pediatrics at CUMC

Administrative Positions

  • Director, Pediatric Gastrointestinal Motility Center

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
3959 Broadway
New York, New York 10032
Phone:
(212) 305-5903
Primary

Research

Clinical Trials

NCT02559570 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

NCT02559817 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, A Multicenter, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation (IBS-C) (ie, Fulfill Rome III Criteria for Child/Adolescent IBS and Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation

COMPLETED

NCT02042183 A Multicentre, Randomised, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation

NCT02138136 A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation

Grants

A MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LUBIPROSTONE IN PAEDIATRIC SUBJECTS AGED = 6 YEARS TO < 18 YEARS WITH FUNCTIONAL CONSTIPATION (P&S Industry Clinical Trial)

Apr 7 2015 - Apr 7 2020

ADVANCES IN MOTILITY AND IN GASTROENTEROLOGY-AIMING FOR THE FUTURE- NASPGHAN CONFERENCE (Federal Gov)

Sep 1 2018 - Aug 31 2019

A MULTI-CENTER STUDY OF THE PREVALENCE OF KNOWN CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY (CSID) GENETIC VARIANTS AND FUNCTIONAL SUCRASE ACTIVITY BY 13C-SUCROSE BREATH TEST IN CHILDREN WITH CHRONIC DIARRHEA OR CHRONIC ABDOMINAL PAIN. (P&S Industry Clinical Trial)

May 12 2014 - May 12 2019

A MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LUBIPROSTONE IN PAEDIATRIC SUBJECTS AGED = 6 YEARS TO < 18 YEARS WITH FUNCTIONAL CONSTIPATION (P&S Industry Clinical Trial)

Apr 4 2014 - Apr 4 2019